Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P, ACCENT I Study Group

Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study.

Tremaine WJ, Brzezinski A, Katz JA, Wolf DC, Fleming TJ, Mordenti J, Strenkoski-Nix LC, Kurth MC, AXYS Ulcerative Colitis Study Group

Normal gene expression in male F344 rat nasal transitional and respiratory epithelium.

Hester SD, Benavides GB, Sartor M, Yoon L, Wolf DC, Morgan KT

An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial.

Sandborn WJ, Feagan BG, Hanauer SB, Present DH, Sutherland LR, Kamm MA, Wolf DC, Baker JP, Hawkey C, Archambault A, Bernstein CN, Novak C, Heath PK, Targan SR, CDP571 Crohn's Disease Study Group

Subchronic sodium chlorate exposure in drinking water results in a concentration-dependent increase in rat thyroid follicular cell hyperplasia.

Hooth MJ, Deangelo AB, George MH, Gaillard ET, Travlos GS, Boorman GA, Wolf DC

Promotion by sodium barbital induces early development but does not increase the multiplicity of hereditary renal tumors in Eker rats.

Wolf DC, Goldsworthy TL, Janszen DB, Harden R, Donner EM, David CS, Everitt JI

Bioavailability of the genotoxic components in coal tar contaminated soils in Fischer 344 rats.

Bordelon NR, Donnelly KC, King LC, Wolf DC, Reeves WR, George SE

Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation.

Gambarin-Gelwan M, Wolf DC, Shapiro R, Schwartz ME, Min AD

Origin and distribution of potassium bromate-induced testicular and peritoneal mesotheliomas in rats.

Crosby LM, Morgan KT, Gaskill B, Wolf DC, DeAngelo AB

Re-evaluation of the 2-year chloroform drinking water carcinogenicity bioassay in Osborne-Mendel rats supports chronic renal tubule injury as the mode of action underlying the renal tumor response.

Hard GC, Boorman GA, Wolf DC

IBD highlights from the 1999 American College of Gastroenterology meeting: infliximab and 6-MP.

Wolf DC

Effects of a thirteen-week inhalation exposure to ethyl tertiary butyl ether on fischer-344 rats and CD-1 mice.

Medinsky MA, Wolf DC, Cattley RC, Wong B, Janszen DB, Farris GM, Wright GA, Bond JA

Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group.

Sandborn WJ, Tremaine WJ, Wolf DC, Targan SR, Sninsky CA, Sutherland LR, Hanauer SB, McDonald JW, Feagan BG, Fedorak RN, Isaacs KL, Pike MG, Mays DC, Lipsky JJ, Gordon S, Kleoudis CS, Murdock RH Jr

Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels.

Sheikh AM, Wolf DC, Lebovics E, Goldberg R, Horowitz HW

Clinical pearls from the 1998 FMAC/CMAC meeting.

Wolf DC